As of 10:34 on July 28, 2026, the Hang Seng Biotechnology Index was down 0.71%, with constituents moving unevenly: JD Health rose 0.90%, CSPC Pharmaceutical Group gained 0.72% and Sino Biopharmaceutical advanced 0.40%, while Insilico Medicine fell 6.16%, MicroPort Robot-B dropped 3.17% and QuantumPharm fell 2.79%. China Universal Hang Seng Biotech ETF (159892) declined 0.41%, according to Jiemian News.
The CSI STAR Market Biopharmaceutical Index fell 2.30%, and China Universal STAR Market Biopharmaceutical ETF (588130) dropped 2.06%. Jiemian News also said U.S. startup Science Corp. received approval on July 28 to sell in the European Union a retinal chip designed to help patients with geographic atrophy regain part of their vision. The report said this was the first time a U.S. brain-computer interface company had moved related devices into large-scale patient use and marked an important step toward commercialization.
Hang Seng Biotechnology Index Falls 0.71% as Science Corp Wins EU Sales Approval for Retinal Chip
2026-07-28 03:23:10
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
片山皋月：日本国债仍具吸引力
